To include your compound in the COVID-19 Resource Center, submit it here.

Caught short

Caught short

Company Offering date Raised $M RA's net profit
Halozyme Therapeutics Inc. (NASDAQ:HALO) 6/23/09 $40.0 $56,742

Read the full 248 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE